These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 849996

  • 1. Pharmacokinetics of cefazolin in patients with renal failure; special reference to hemodialysis.
    Brogard JM, Pinget M, Brandt C, Lavillaureix J.
    J Clin Pharmacol; 1977 Apr; 17(4):225-30. PubMed ID: 849996
    [Abstract] [Full Text] [Related]

  • 2. Effects of renal failure and dialysis on cefazolin pharmacokinetics.
    Madhavan T, Yaremchuk K, Levin N, Fisher E, Cox F, Burch K, Haas E, Pohlod D, Quinn EL.
    Antimicrob Agents Chemother; 1975 Jul; 8(1):63-6. PubMed ID: 1164008
    [Abstract] [Full Text] [Related]

  • 3. Cefazolin in children with renal insufficiency.
    Hiner LB, Baluarte HJ, Polinsky MS, Gruskin AB.
    J Pediatr; 1980 Feb; 96(2):335-9. PubMed ID: 7351609
    [Abstract] [Full Text] [Related]

  • 4. Dosage adjustments of cefazolin according to the pharmacokinetics of this new cephalosporin.
    Lavillaureix J, Brogard JM, Pinget M, Ledoux F.
    Infection; 1975 Feb; 3(2):105-14. PubMed ID: 1102452
    [Abstract] [Full Text] [Related]

  • 5. The serum half-life and urine concentrations of cephazolin sodium in patients with terminal renal failure: effect of haemodialysis.
    Eastwood JB, Gower PE, Curtis JR.
    Scott Med J; 1976 Sep; 20(5):240-3. PubMed ID: 1265473
    [Abstract] [Full Text] [Related]

  • 6. Cefamandole pharmacokinetics and dosage adjustments in relation to renal function.
    Brogard JM, Kopferschmitt J, Spach MO, Grudet O, Lavillaureix J.
    J Clin Pharmacol; 1979 Jul; 19(7):366-77. PubMed ID: 479381
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis.
    Chodos J, Francke EL, Saltzman M, Neu HC.
    Ther Drug Monit; 1981 Jul; 3(1):71-4. PubMed ID: 6262952
    [Abstract] [Full Text] [Related]

  • 8. Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans.
    Lee FH, Pfeffer M, Van Harken DR, Smyth RD, Hottendorf GH.
    Antimicrob Agents Chemother; 1980 Feb; 17(2):188-92. PubMed ID: 7387141
    [Abstract] [Full Text] [Related]

  • 9. [Plasma half-life of cefazoline. Study in the normal subject and in the patient with renal insufficiency].
    Humbert G, Fillastre JP, Leroy A.
    Nouv Presse Med; 1975 Oct 18; 4(35):2523-6. PubMed ID: 1196876
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.
    Leroy A, Humbert G, Godin M, Fillastre JP.
    Antimicrob Agents Chemother; 1980 Mar 18; 17(3):344-9. PubMed ID: 7425600
    [Abstract] [Full Text] [Related]

  • 11. Determination of cefalexin pharmacokinetics and dosage adjustments in relation to renal function.
    Brogard JM, Pinget M, Dorner M, Lavillaureix J.
    J Clin Pharmacol; 1975 Oct 18; 15(10):666-73. PubMed ID: 1184770
    [Abstract] [Full Text] [Related]

  • 12. Absorption, distribution and elimination of cefazolin in patients with normal renal function.
    Bergan T, Digranes A, Schreiner A.
    Chemotherapy; 1978 Oct 18; 24(5):277-82. PubMed ID: 352636
    [Abstract] [Full Text] [Related]

  • 13. Moxalactam pharmacokinetics during hemodialysis.
    Aronoff GR, Sloan RS, Mong SA, Luft FC, Kleit SA.
    Antimicrob Agents Chemother; 1981 Apr 18; 19(4):575-7. PubMed ID: 6454386
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacokinetics of cefazolin during hemosorption and hemodialysis].
    Firsov AA, Treskina OS, Nasonov VN, Umnova LV, Cherniakov VL.
    Antibiot Med Biotekhnol; 1986 Nov 18; 31(11):871-4. PubMed ID: 3813510
    [Abstract] [Full Text] [Related]

  • 15. Cefazolin dialytic clearance by high-efficiency and high-flux hemodialyzers.
    Sowinski KM, Mueller BA, Grabe DW, Manley HJ, Frye RF, Bailie GR, Marx MA.
    Am J Kidney Dis; 2001 Apr 18; 37(4):766-76. PubMed ID: 11273877
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency.
    Humbert G, Leroy A, Fillastre JP, Godin M.
    Chemotherapy; 1979 Apr 18; 25(4):189-95. PubMed ID: 456077
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of cephalosporins in patients with normal or reduced renal function.
    Andriole VT.
    J Infect Dis; 1978 May 18; 137 Suppl():S88-S99. PubMed ID: 349098
    [Abstract] [Full Text] [Related]

  • 18. Renal failure, hemodialysis, and nafcillin kinetics.
    Rudnick M, Morrison G, Walker B, Singer I.
    Clin Pharmacol Ther; 1976 Oct 18; 20(4):413-23. PubMed ID: 975716
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of cefamandole in patients with renal failure.
    Meyers BR, Hirschman SZ.
    Antimicrob Agents Chemother; 1977 Feb 18; 11(2):248-50. PubMed ID: 848929
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH, Knupp CA, Forgue ST, Matzke GR, Guay DR, Pittman KA.
    Clin Pharmacol Ther; 1990 Sep 18; 48(3):268-76. PubMed ID: 2401125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.